Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
BERLIN (Reuters) - BioNTech Chief Executive Ugur Sahin said on Monday he was confident a COVID-19 vaccine co-developed by his company would be effective against a variant of the coronavirus that has emerged in Britain.
He said on Bild TV that the German company would investigate the mutation in the coming days but that he viewed the matter with "with a degree of soberness".
Early results on Pfizer COVID-19 vaccine encouraging, says Israeli HMO
JERUSALEM (Reuters) - Fewer than 0.01% of people who received Pfizer’s COVID-19 vaccine have contracted the virus more than a week after receiving the second dose, a leading Israeli healthcare provider said on Monday.